News Eisai, Takeda and GARDP hunt for new antibiotics The not-for-profit Global Antibiotic Research and Development Partnership has joined forces with Eisai and Takeda to search for new antibiotics.
Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
News Merck to file for new use for antibiotic Zerbaxa Antibiotic matched standard of care in phase 3 trial
Partner Content Partner Content SMi’s Exclusive Interview with MedImmune Principal Scientist... An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released
News Novartis to cease antibiotic R&D despite superbug threat Yet another big pharma quits antibiotics research
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
News Test could end uncertainty in inherited muscle diseases A new study suggests long-read 'nanopore' sequencing could transform the diagnosis of inherited diseases and unlock new insights for drug discovery.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.